David M. Knott’s Acceleron Pharma XLRN Stock Holding History

David M. Knott’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$172K	Buy	+1,000	New	+$131K	0.06%	102
2020 Q2	–	Sell	-805	Closed	-$72K	–	105
2020 Q1	$72K	Sell	805 -4,742	-85%	-$369K	0.05%	96
2019 Q4	$294K	Sell	5,547 -16,202	-74%	-$739K	0.12%	72
2019 Q3	$859K	Buy	21,749 +3,949	+22%	+$171K	0.36%	46
2019 Q2	$731K	Buy	17,800 +400	+2%	+$16.6K	0.31%	52
2019 Q1	$810K	Hold	17,400	–	–	0.32%	48
2018 Q4	$758K	Buy	17,400 +1,000	+6%	+$50K	0.36%	46
2018 Q3	$939K	Hold	16,400	–	–	0.3%	46
2018 Q2	$796K	Buy	+16,400	New	+$598K	0.3%	49

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

David M. Knott's XLRN Position: Q3 2021 in Review

David M. Knott opened a new position in Acceleron Pharma (XLRN) in Q3 2021: 1,000 shares worth $172K. The stake represents 0.06% of the portfolio and ranks #102 among its holdings. This is a return to the name: David M. Knott previously reported a position in XLRN as recently as Q1 2020.

David M. Knott first reported a position in XLRN in Q2 2018 and has held it in 9 quarters since. The position peaked at $939K in Q3 2018. 330 funds tracked by Wall St. Rank hold XLRN as of Q3 2021.

David M. Knott held 1,000 shares of Acceleron Pharma worth $172K as of Q3 2021.
Acceleron Pharma was a new David M. Knott position in Q3 2021.
Acceleron Pharma made up 0.06% of David M. Knott's portfolio in Q3 2021, its #102 holding.
David M. Knott first reported a position in Acceleron Pharma in Q2 2018 and has held it in 9 quarters since.
David M. Knott's Acceleron Pharma position peaked at $939K in Q3 2018.
330 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.